Editorial · 2019 · Open access

Are we seeing a resurgence in the use of natural products for new drug discovery?

Feng Li, Yongli Wang, Dapeng Li, Yilun Chen, Q. Ping Dou

Expert Opinion on Drug Discovery, 14(5), 417–420 · Published 27 February 2019 · DOI 10.1080/17460441.2019.1582639

Free PDFView at the publisherCite this paper

In brief

“Are we seeing a resurgence in the use of natural products for new drug discovery?” is an 2019 editorial by Feng Li and 4 co-authors, published in Expert Opinion on Drug Discovery. OpenAlex counts 77 citations as of 15 November 2026. It is open access: the full text is free to read at Expert Opinion on Drug Discovery.

Citations
77
Most cited in
2021 (18)
References
19
Authors
5

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Li, F., Wang, Y., Li, D., Chen, Y., & Dou, Q. P. (2019). Are we seeing a resurgence in the use of natural products for new drug discovery? Expert Opinion on Drug Discovery, 14(5), 417–420. https://doi.org/10.1080/17460441.2019.1582639

MLA 9

Li, Feng, et al. “Are we seeing a resurgence in the use of natural products for new drug discovery?” Expert Opinion on Drug Discovery, vol. 14, no. 5, 2019, pp. 417–420. https://doi.org/10.1080/17460441.2019.1582639.

Chicago

Li, Feng, Yongli Wang, Dapeng Li, Yilun Chen, and Q. Ping Dou. 2019. “Are we seeing a resurgence in the use of natural products for new drug discovery?” Expert Opinion on Drug Discovery 14 (5): 417–420. https://doi.org/10.1080/17460441.2019.1582639.

Harvard

Li, F. et al. (2019) ‘Are we seeing a resurgence in the use of natural products for new drug discovery?’, Expert Opinion on Drug Discovery, 14(5), pp. 417–420. doi:10.1080/17460441.2019.1582639.

IEEE

F. Li, Y. Wang, D. Li, Y. Chen, and Q. P. Dou, “Are we seeing a resurgence in the use of natural products for new drug discovery?,” Expert Opinion on Drug Discovery, vol. 14, no. 5, pp. 417–420, 2019, doi: 10.1080/17460441.2019.1582639.

BibTeX

@article{li2019seeing,
  title     = {{Are we seeing a resurgence in the use of natural products for new drug discovery?}},
  author    = {Li, Feng and Wang, Yongli and Li, Dapeng and Chen, Yilun and Dou, Q. Ping},
  journal   = {Expert Opinion on Drug Discovery},
  year      = {2019},
  volume    = {14},
  number    = {5},
  pages     = {417--420},
  doi       = {10.1080/17460441.2019.1582639},
  url       = {https://doi.org/10.1080/17460441.2019.1582639}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201955
20201515
20211818
202299
20231313
202466
202533
202688

Topic and keywords

Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis

  • natural products
  • drug discovery
  • natural product-derived drugs
  • structural diversity
  • biological activity
  • drug development

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Li, F., Wang, Y., Li, D., Chen, Y., & Dou, Q. P. (2019). Are we seeing a resurgence in the use of natural products for new drug discovery? Expert Opinion on Drug Discovery, 14(5), 417–420. https://doi.org/10.1080/17460441.2019.1582639

How many times has this paper been cited?

77 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Expert Opinion on Drug Discovery.

Who wrote this paper?

Feng Li, Yongli Wang, Dapeng Li, Yilun Chen, Q. Ping Dou.

What is the DOI of this paper?

10.1080/17460441.2019.1582639. The permanent link is https://doi.org/10.1080/17460441.2019.1582639.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.